These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8150777)
1. Bisphosphonates in breast cancer patients with skeletal metastases. Shapiro CL Hematol Oncol Clin North Am; 1994 Feb; 8(1):153-63. PubMed ID: 8150777 [TBL] [Abstract][Full Text] [Related]
2. The role of bisphosphonates in breast cancer. Coleman RE Breast; 2004 Dec; 13 Suppl 1():S19-28. PubMed ID: 15585379 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates in breast cancer: antitumor effects. Aft R Clin Adv Hematol Oncol; 2011 Apr; 9(4):292-9. PubMed ID: 21558988 [TBL] [Abstract][Full Text] [Related]
4. Oral pamidronate in the prevention and treatment of skeletal metastases in patients with breast cancer. van Holten-Verzantvoort AT; Papapoulos SE Medicina (B Aires); 1997; 57 Suppl 1():109-13. PubMed ID: 9567363 [TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of bone metastases in breast cancer patients. Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337 [TBL] [Abstract][Full Text] [Related]
6. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer. Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526 [TBL] [Abstract][Full Text] [Related]
7. [Bisphosphonates and breast cancer]. Vehmanen L; Saarto T Duodecim; 2010; 126(10):1229-37. PubMed ID: 20597352 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease. Kanakis I; Kousidou OCh; Karamanos NK In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191 [TBL] [Abstract][Full Text] [Related]
9. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates. Mystakidou K; Katsouda E; Stathopoulou E; Vlahos L Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956 [TBL] [Abstract][Full Text] [Related]
10. Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer. Clemons M; Dranitsaris G; Cole D; Gainford MC Oncologist; 2006 Mar; 11(3):227-33. PubMed ID: 16549806 [TBL] [Abstract][Full Text] [Related]
11. Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer. Liauw W; Segelov E; Lih A; Dunleavy R; Links M; Ward R BMC Cancer; 2005 Jul; 5():89. PubMed ID: 16048654 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates for breast cancer: questions answered, questions remaining. Layman R; Olson K; Van Poznak C Hematol Oncol Clin North Am; 2007 Apr; 21(2):341-67. PubMed ID: 17512453 [TBL] [Abstract][Full Text] [Related]
14. [Current use of bisphosphonates in clinical oncology]. Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372 [TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate therapy for patients with breast carcinoma. Plunkett TA; Rubens RD Cancer; 2003 Feb; 97(3 Suppl):854-8. PubMed ID: 12548586 [TBL] [Abstract][Full Text] [Related]
16. New generation of bisphosphonates: broad clinical utility in breast and prostate cancer. Rosen LS Oncology (Williston Park); 2004 May; 18(5 Suppl 3):26-32. PubMed ID: 15202585 [TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates for cancer patients: why, how, and when? Body JJ; Mancini I Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223 [TBL] [Abstract][Full Text] [Related]
18. [Bisphosphonates in the therapy of cancer patients]. Jantunen E; Kumpulainen E Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857 [No Abstract] [Full Text] [Related]
19. On the horizon: can bisphosphonates prevent bone metastases? Coleman R Breast; 2007 Dec; 16 Suppl 3():S21-7. PubMed ID: 17988867 [TBL] [Abstract][Full Text] [Related]
20. Clinical trials in metastatic breast cancer to bone: past--present--future. Body JJ Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]